EDAP TMS S.A. (EDAP) Completes FDA Q&A Session For Its Ablatherm-HIFU Pre-Market Approval Application
3/20/2014 8:49:47 AM
LYON, France, March 20, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it has completed its response to questions from the FDA regarding the Company's Ablatherm-HIFU Pre-Market Approval ("PMA") application, closing this step within the U.S. Food and Drug Administration ("FDA") review process.
Help employers find you! Check out all the jobs and post your resume.
comments powered by